Study of Epratuzumab in Systemic Lupus Erythematosus

Withdrawn before enrolling · Phase 3

Conditions studied: Systemic Lupus Erythematosus

In brief

Epratuzumab is an investigational antibody designed to help treat SLE. The purpose is to evaluate safety and long term efficacy in concert with standard SLE treatments

Key facts

Study ID

NCT00382837

Run by

UCB Pharma

People needed

0

Starts

2007-01-01

Last updated by the study team

2014-05-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have completed SL0003 Alleviate A through 48 weeks

You may not qualify if…

• Development of toxicity to Epratuzumab
• Significant protocol deviations from SL0003 Study.

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — Los Angeles, California, United States
• Study site — Upland, California, United States
• Study site — Farmington, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Aventura, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Baltimore, Maryland, United States
• Study site — New York, New York, United States
• Study site — Syracuse, New York, United States
• Study site — The Bronx, New York, United States
• Study site — Durham, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Gallipolis, Ohio, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Charleston, South Carolina, United States
• Study site — Dallas, Texas, United States
• Study site — Arlington, Virginia, United States
• Study site — Edmonds, Washington, United States
• Study site — Brussels, Belgium
• Study site — Liège, Belgium
• Study site — Rio de Janeiro, Rio de Janeiro, Brazil
• Study site — Goiânia, Brazil
• Study site — Rio de Janeiro, Brazil
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.